sofosbuvir
chemical compound
Facts
20 properties- Instance of
- type of chemical entity
- Official website
- www.sovaldi.com
- Subclass of
- nucleoside analogue
- Has use
- medication
- Active ingredient in
- Sovaldi, sofosbuvir/velpatasvir
- Canonical SMILES
- CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3
- Catalog
- CAS COVID-19 Anti-Viral Candidate Compounds
- Chemical formula
- C₂₂H₂₉FN₃O₉P
- Defined daily dose
- 0.4 g
- Discoverer or inventor
- Michael J. Sofia
- Isomeric SMILES
- C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3
- Legal status (medicine)
- boxed warning
- LiverTox likelihood score
- LiverTox toxicity likelihood category E*
- Mass
- 529.162544 Da
- Medical condition treated
- hepatitis C, hepatitis, liver cirrhosis
- Pregnancy category
- US pregnancy category B
- Significant drug interaction
- amiodarone
- Stereoisomer of
- L-Alanine, N-[[P(R),2′R]-2′-deoxy-2′-fluoro-2′-methyl-P-phenyl-5′-uridylyl]-, 1-methylethyl ester
- Subject has role
- antiviral agent, WHO essential medicines, active ingredient, antiviral drug, bactericide
🏷️ Also known as
en sofosbuvir
en Sofosbuvir
en Sovaldi®
en GI-7977
en GS-7977
en isopropyl (2S)-2-{[(S)-{[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]amino}propanoate
en PSI 7977
en S)-Isopropyl 2-((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4- dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)- (phenoxy)phosphorylamino)propanoate
en Soforal
ar سوفالدي
ar سوفوسبوفير
el σοφοσμπουβίρη
fa سوفوسباویر
fi sofosbuviiri
ja ソホスブビル
pl Sofosbuwir
ru GS-7977
ru PSI-7977
ru Soforal
ru Sofosbuvir
🔖 Identifiers · 37
- OpenAlex ID
- C2778390639
- CAB ID
- 33918
- CAS Registry Number
- 1190307-88-0
- ChEBI ID
- 85083
- ChEMBL ID
- CHEMBL1259059
- ChemSpider ID
- 26286922
- DSSTox substance ID
- DTXSID701027632
- DeCS ID
- 55930
- DrugBank ID
- DB08934
- DrugCentral ID
- 4811
- EC number
- 695-717-4
Show all 37 identifiers +25
- ECHA Substance Infocard ID
- 100.224.393
- Electronic Essential Medicines List medicine ID
- 296
- Freebase ID
- /m/0hncg8p
- Golden ID (archived)
- Sofosbuvir-YERWX5
- Guide to Pharmacology Ligand ID
- 7368
- HSDB ID
- 8226
- InChIKey
- TTZHDVOVKQGIBA-IQWMDFIBSA-N
- KEGG ID
- D10366
- LiverTox ID
- Sofosbuvir
- MeSH descriptor ID
- D000069474
- MedlinePlus drug identifier
- a614014
- Microsoft Academic ID (discontinued)
- 2778390639
- NDF-RT ID
- N0000189539
- PDB ligand ID
- WG6
- Probes And Drugs ID
- PD010569
- PubChem CID
- 45375808
- Reaxys registry number
- 20867484
- RxNorm CUI
- 1484911
- SureChEMBL ID
- 2010114
- UMLS CUI
- C2976303
- UNII
- WJ6CA3ZU8B
- UniChem compound ID
- 1002085
- WikiProjectMed ID
- Sofosbuvir
🔗 Connections
Belongs to 5
Subject has role 4
Medical condition treated 3
← Drug or therapy used for treatment 3
Significant drug interaction 2
← Significant drug interaction 2
Active ingredient in 1
Has use 1
Legal status (medicine) 1
Subclass of 1
← EU Knowledge Graph item ID 1
← Has active ingredient 1
Press Enter · cited answer in seconds
0 sources
Summary
sofosbuvir is a type of chemical entity[1]. sofosbuvir is a type of nucleoside analogue[2].
Key Facts
- Discoverer or inventor: Michael J. Sofia[3]
- Canonical SMILES: CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3[4]
- Chemical formula: C₂₂H₂₉FN₃O₉P[5]
- Has use: medication[6]
- Has part(s): oxygen[7], fluorine[8], carbon[9]
- Significant drug interaction: amiodarone[10]
- Official website: http://www.sovaldi.com/[11]
- Catalog: CAS COVID-19 Anti-Viral Candidate Compounds[12]
- Isomeric SMILES: CC@@HNP@(OC[C@@H]1C@HO)OC3=CC=CC=C3C@@HNP@(OC[C@@H]1C@HO)OC3=CC=CC=C3">[13]
- Mass: 529.162544 dalton[14]
- Medical condition treated: hepatitis C[15], hepatitis[16], liver cirrhosis[17]
- Subject has role: antiviral agent[18], WHO essential medicines[19], active ingredient[20], antiviral drug[21], bactericide[22]
- Stereoisomer of: L-Alanine, N-[[P(R),2′R]-2′-deoxy-2′-fluoro-2′-methyl-P-phenyl-5′-uridylyl]-, 1-methylethyl ester[23]
- Pregnancy category: US pregnancy category B[24]
- Legal status (medicine): boxed warning[25]
- Active ingredient in: Sovaldi[26], sofosbuvir/velpatasvir[27]
- Defined daily dose: 0.4 g[28]
- On focus list of Wikimedia project: WikiProject Zika Corpus[29]
- LiverTox likelihood score: LiverTox toxicity likelihood category E*[30]